POMC Genotype

If you have struggled with severe weight gain since childhood, have a family member with the same pattern, or have unexplained adrenal or pigmentation issues alongside obesity, the answer may sit inside a single gene. POMC (pro-opiomelanocortin) is the master template your brain uses to build the chemical signals that tell you when to stop eating, make stress hormones, and produce pigment in your skin and hair.

This is a one-time genetic test that reads the DNA of your POMC gene. Rare high-impact mutations in this gene cause some of the most dramatic forms of inherited obesity and are now treatable with a targeted prescription medication. Knowing your genotype can reshape how you and your doctors approach weight, hormones, and family planning.

What POMC Actually Does

The POMC gene encodes a single large protein that your body chops into smaller pieces. Some of those pieces tell your brain you are full. Others tell your adrenal glands to make cortisol, the main stress hormone. Still others give your hair and skin their color. When POMC works normally, you feel satisfied after eating, handle physiological stress, and produce pigment without issue.

When POMC is broken on both copies of the gene (one inherited from each parent), the entire system collapses. Children with this complete loss develop severe obesity early in life, cannot make enough cortisol, and often have red hair and pale skin, though only about half of patients show this classic pigmentation pattern and some, particularly those of non-European ancestry, have normal pigmentation. This combination defined a new monogenic endocrine disorder when it was first described in humans.

Severe Obesity From Inherited POMC Loss

When both copies of POMC carry harmful mutations, the result is striking and consistent. In a series of 41 people carrying two harmful POMC variants, all had early-onset severe obesity. Among the 20 patients in that series who underwent detailed endocrine evaluation, 40% had combined pituitary hormone deficiency, meaning multiple hormone systems failed at once, always alongside low cortisol.

This is a different problem than common obesity. The hunger drive is biological and overwhelming, not a matter of willpower. Children eat constantly because the brain never receives the signal that says stop. This form of obesity now has a treatment. Two patients in that same series even recovered their reproductive hormone function after starting a drug that activates the downstream receptor (called setmelanotide, an MC4R agonist) that POMC normally signals through.

What Carrying One Bad Copy Means

Most people who carry a POMC variant inherit only one bad copy, not two. The evidence here is more nuanced. In one family with a POMC null mutation, 11 of 12 single-copy carriers were overweight or obese compared with only 1 of 7 relatives without the variant. That looked like a meaningful effect.

But larger analyses of UK Biobank exome data tell a more modest story. An earlier analysis of roughly 190,000 exomes found that single-copy carriers of rare harmful POMC variants were no more likely to have obesity than non-carriers, with only about a 0.1 unit increase in BMI on average. A more recent analysis covering roughly 419,000 participants found a larger effect, with rare POMC variants associated with 0.5 to 2.5 kg/m² higher BMI in gene-burden tests, although the proportion of carriers who actually developed obesity was not significantly different from non-carriers. The picture is that single-copy POMC variants are not a dominant cause of severe obesity, but the average BMI nudge upward may be larger than the earliest large analyses suggested.

A separate clinic-based study of people with severe obesity found that single-copy variants across the broader appetite pathway (including POMC, leptin, leptin receptor, and PCSK1) were present in 6.7% of cases. Some of these carriers had weight problems nearly as severe as people carrying two bad copies, especially when the variant was particularly damaging or when variants were stacked across multiple genes in the pathway.

Specific Variants Worth Knowing

Not all POMC variants act the same way. Some change a single letter in the DNA in a place that disrupts how the protein is cut into its working pieces. The R236G variant creates a fused protein that binds to the appetite receptor but barely activates it, leaving the brain's stop-eating signal muted. Variants like this were found in 0.88% of people with early-onset obesity compared with 0.22% of controls.

Other variants hit the protein's signal peptide, the tag that tells cells where to send the protein. These can impair POMC processing entirely and have been linked to obesity, type 2 diabetes, hypertension, and coronary heart disease in family studies. In severely obese Italians, three specific exon 3 variants (P231L, E244X, R236G) were found only in obese subjects and never in controls.

Common Variants and Body Shape

Beyond rare high-impact mutations, common DNA differences near the POMC gene can subtly shape body weight and where you store fat. A large family-based study found that common noncoding variants (C8246T and C1032G) were significantly associated with waist-to-hip ratio but not with overall BMI or leptin levels. A separate study in a large group of women, however, linked the 8246T allele to higher overall BMI and total body fat. Together these studies suggest the common variants influence fat distribution and, in some populations, total body weight as well.

A 3' UTR variant called rs1042571 was also significantly associated with higher BMI in European Americans. These common variants have small individual effects but help explain why some people carry weight in the middle of the body even when their BMI is normal.

The Epigenetic Layer

DNA sequence is not the only thing that matters. Chemical marks on top of the DNA, called methylation, control how strongly POMC is read by the cell. A region of the POMC gene called the variably methylated region (VMR) shows person-to-person differences in methylation that are strongly associated with BMI and appear to be set early in embryonic development.

Follow-up work showed that POMC hypermethylation acts as a stable, lifelong trait that raises obesity risk roughly 1.4-fold by reducing POMC expression in brain cells. Adults with this hypermethylation pattern lost about 4.7% of their body weight over nine months when treated with an MC4R agonist. Standard POMC genotype tests read the DNA sequence and do not capture methylation, so this is a separate dimension of POMC biology.

How To Think About a Result

Carrying a POMC variant is not destiny. The single most important variable is zygosity: do you carry one copy of the variant or two? Two harmful copies cause a severe, recognizable syndrome that is usually diagnosed in childhood. One harmful copy modestly raises BMI for some carriers but does not, on its own, cause monogenic obesity in the way clinic-based case reports once suggested.

The other key variable is variant type. A complete loss-of-function variant carries far different weight than a missense variant in a regulatory region. A variant that disrupts how the protein is cut into pieces (like R236G) is more concerning than a variant of unknown significance in a noncoding region. A skilled interpretation matters more than the binary positive or negative.

One-Time Result, Lifetime Use

This is a germline DNA test, meaning the result reflects the genome you were born with. Your POMC genotype will not change over your lifetime, so this test does not need to be repeated. The value comes from integrating the result into ongoing decisions: weight management approach, hormone monitoring if you carry two harmful copies, family planning, and treatment selection if a targeted therapy becomes appropriate.

If you do carry a clinically significant variant, what changes is not the genotype but the phenotypes you should track. People with biallelic POMC variants need lifelong monitoring of cortisol and other pituitary hormones. People with rare missense variants tied to obesity benefit from earlier and more aggressive metabolic monitoring, including fasting glucose, insulin, and lipids. The cadence depends on your specific variant and your other risk factors, not on retesting the gene.

What an Unexpected Result Should Prompt

If you discover you carry two harmful copies of POMC, the next step is a full pituitary hormone workup with an endocrinologist. Cortisol deficiency can be life-threatening if missed, and several other hormone axes (growth hormone, thyroid, reproductive hormones) may also be affected. You may also be a candidate for setmelanotide, the targeted MC4R agonist that has shown substantial weight loss in this group.

If you carry one copy of a rare variant in a clinically relevant region, the practical implications are smaller but real. A conversation with an obesity medicine specialist or genetic counselor can help interpret your specific variant, especially when combined with other testing in the appetite pathway (such as MC4R, LEP, LEPR, and PCSK1). Variants stacked across this pathway can produce a phenotype closer to monogenic obesity even when no single variant looks dramatic.

Family members deserve a conversation too. POMC is inherited, so siblings, children, and parents of someone with a clinically significant variant may carry it as well. If a child in your family has early-onset severe obesity, especially with red hair or unexplained low cortisol, share your result with their pediatrician.

Why a Single Reading Is Reliable Here

Unlike a hormone level that fluctuates, a genetic test reads the same DNA sequence whether you take it today or in ten years. That said, a few situations can produce misleading results. The test only detects variants the assay is designed to find, so a negative result does not guarantee you have no rare POMC variant anywhere in the gene. Direct-to-consumer chip-based tests typically cover fewer variants than clinical-grade sequencing of the whole POMC coding region.

Variant of uncertain significance (VUS) results are another source of confusion. A VUS means the lab found a difference in your DNA but does not yet know whether it causes disease. Over time, these can be reclassified as evidence accumulates. The meaning of a specific variant also depends on ancestry, because some variants are common in one population and rare in another. The clinical interpretation needs to account for your background.